Soleus Capital Management, L.P. - TCR2 THERAPEUTICS INC ownership

TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 84 filers reported holding TCR2 THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.96 and the average weighting 0.5%.

Quarter-by-quarter ownership
Soleus Capital Management, L.P. ownership history of TCR2 THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$780,000
-75.1%
47,537
-66.6%
0.12%
-78.8%
Q1 2021$3,138,000
-49.2%
142,137
-28.9%
0.56%
-30.8%
Q4 2020$6,182,000
+7.9%
199,867
-29.1%
0.82%
-73.1%
Q3 2020$5,731,000
+2318.1%
282,041
+821.0%
3.04%
+1000.7%
Q1 2020$237,00030,6240.28%
Other shareholders
TCR2 THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,050,865$4,046,8141.69%
MPM BioImpact LLC 3,370,982$3,367,6110.87%
TANG CAPITAL MANAGEMENT LLC 2,738,947$2,735,6600.40%
Newtyn Management, LLC 1,075,000$1,073,7100.22%
HARBOR CAPITAL ADVISORS, INC. 68,230$68,1480.07%
Artal Group S.A. 750,000$7490.04%
Oasis Management Co Ltd. 200,000$199,7600.04%
Redmile Group, LLC 731,379$730,5010.03%
X-Square Capital, LLC 31,919$320.02%
CORNERCAP INVESTMENT COUNSEL INC 68,035$67,9530.01%
View complete list of TCR2 THERAPEUTICS INC shareholders